About
Axolbio provides human induced pluripotent stem cell (iPSC)-derived cells and laboratory services to support preclinical drug discovery and disease research in areas including neuroscience, cardiovascular, ophthalmology, and dermatology.
Explore Axolbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.